JSC Bratskchemsintez will open a new manufacturing site of medicinal products in September 2017. According to the corporate management, the production will operate in compliance with the international GMP standards, thus it will be safe for the environment.
New deadlines for launching the pharmaceutical plant in Bratsk were announced after a working meeting of Sergey Levchenko, Governor of Irkutsk region, and Punia Vikram Singh, President of JSC Pharmasyntez.
Reconstruction and development costs of the site amounted to 1,5 billion rubles.
The new plant will produce active pharmaceutical ingredients for innovative medicinal drugs. In particular, it is planned to manufacture here perchlozon, which is required for the production of antituberculosis medication. This medication, developed by Irkutsk scientists, was included in the List of Vital and Essential Drugs.
Production of antituberculosis and antiretroviral drugs will be launched in the 4th quarter 2017, anticancer medicinal products – since 2018.